Kurt Tauer, MD, FACP, discusses arguments in favor of and against biosimilars in oncology.
Kurt Tauer, MD, FACP
Advertisement
Articles by Kurt Tauer, MD, FACP
Advertisement
Latest Updated Articles
Dr. Tauer on Arguments in Favor of and Against Biosimilars in OncologyPublished: November 9th 2019 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
2
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
3
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
4
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
5